These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10509326)

  • 21. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
    Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.
    Heney M; Alipour M; Vergidis D; Omri A; Mugabe C; Th'ng J; Suntres Z
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1172-80. PubMed ID: 21164564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer].
    Liu F; Jiang ZF; Song ST; Liu XQ; Wang T; Yan M; Zhang SH; Hao CF; Sun JZ; Shen G
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):56-8. PubMed ID: 15771802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin/paclitaxel combination does not expose breast cancer patients to excessive cardiac risk.
    Oncology (Williston Park); 2001 Jul; 15(7):830. PubMed ID: 11499684
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
    Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weekly paclitaxel--an effective treatment for advanced breast cancer.
    Kellokumpu-Lehtinen P; Tuunanen T; Asola R; Elomaa L; Heikkinen M; Kokko R; Järvenpää R; Lehtinen I; Maiche A; Kaleva-Kerola J; Huusko M; Möykkynen K; Ala-Luhtala T
    Anticancer Res; 2013 Jun; 33(6):2623-7. PubMed ID: 23749918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of docetaxel/doxorubicin combination in metastatic breast cancer.
    Diéras V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):31-3. PubMed ID: 9364539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
    Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-containing combination chemotherapy for metastatic breast cancer.
    Hortobagyi GN; Ibrahim N
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):53-7. PubMed ID: 8629039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
    Campone M; Fumoleau P
    Bull Cancer; 2002 Mar; 89(3):275-82. PubMed ID: 11940467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?
    Pace A; Nisticò C; Cuppone F; Bria E; Galiè E; Graziano G; Natoli G; Sperduti I; Jandolo B; Calabretta F; Tomao S; Terzoli E
    Clin Breast Cancer; 2007 Apr; 7(7):550-4. PubMed ID: 17509163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Feasibility, activity, and change in the level of blood paclitaxel concentration after weekly paclitaxel therapy for a patient with recurrent ovarian cancer].
    Ishioka S; Sagae S; Kudo R
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1017-21. PubMed ID: 11478132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
    Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
    Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA
    Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paclitaxel in therapy of breast carcinoma. Value and perspectives].
    Klaassen U; Seeber S
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():7-10. PubMed ID: 9082172
    [No Abstract]   [Full Text] [Related]  

  • 38. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
    Schwartsmann G; Mans DR; Menke CH; Xavier N; Caleffi M; Ferreira Filho AF; Schunemann H; Kalakun L; Koya R; Pohlman P; Venegas LF
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):24-9. PubMed ID: 9144687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.
    Christodoulou C; Klouvas G; Pateli A; Mellou S; Sgouros J; Skarlos DV
    Anticancer Res; 2003; 23(1B):737-44. PubMed ID: 12680177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.